WHY IT MATTERS:
The new program provides patients with a shorter recovery time, better outcomes and the ability to potentially cure AFib. For example, the minimally invasive hybrid procedure requires a 1-to-2-night hospital stay and then the patient is back to a normal routine within two weeks. Compared to a 3-month recovery from broken bones with open heart surgery, which historically was the only way to eliminate atrial fibrillation from the outside of the heart.
THE BIG PICTURE:
According to the Centers for Disease Control and Prevention (CDC), AFib is responsible for more than 454,000 hospitalizations and roughly 158,000 deaths each year in the U.S. In addition, the CDC forecast 12.1 million people in the United States will have AFib in 2030.
ABOUT THE NEW PROGRAM:
This FDA-approved hybrid approach involves two procedures to help treat patients with long-standing Atrial Fibrillation (AFib). By offering a minimally invasive procedure, patients can improve, and potentially cure, the most common type of heart arrhythmia.
“Instead of opening your chest and going inside the heart to fix AFib, we can make the same type of lesions on the outside of the heart using cameras to guide us, without stopping it, and only make a 2-centimeter incision at the base of your chest,” said Dr. David Spurlock, a cardiothoracic surgeon at AdventHealth Orlando.
"In this second procedure, we access the inside of the heart through the veins in the legs and cauterize off certain areas of the patient's heart, “ said Dr. Mahmoud Altawil, an electrophysiologist at AdventHealth Orlando. “By having both procedures done, one outside the heart and the other inside, it increases the patient’s chance of being able to maintain normal rhythm long term.”
Altawil says studies have shown many long-standing AFib patients do better with this hybrid, two-procedure approach and many are able to come off blood thinners, which is an added benefit.
